Acorah Software Products - Accounts Production 16.2.850 false true false true No description of principal activity 16 February 2024 28 February 2025 28 February 2025 15494603 Mr V Frais iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15494603 2024-02-15 15494603 2025-02-28 15494603 2024-02-16 2025-02-28 15494603 frs-core:CurrentFinancialInstruments 2025-02-28 15494603 frs-bus:PrivateLimitedCompanyLtd 2024-02-16 2025-02-28 15494603 frs-bus:FilletedAccounts 2024-02-16 2025-02-28 15494603 frs-bus:Micro-entities 2024-02-16 2025-02-28 15494603 frs-bus:AuditExempt-NoAccountantsReport 2024-02-16 2025-02-28 15494603 frs-bus:Director1 2024-02-16 2025-02-28
Registered number: 15494603
Immune Booster Ltd
Unaudited Financial Statements
For the Period 16 February 2024 to 28 February 2025
CIGMA ACCOUNTING LTD
Balance Sheet
Registered number: 15494603
28 February 2025
£
Current assets 2,145
Creditors: Amounts Falling Due Within One Year (12,747 )
NET CURRENT LIABILITIES (10,602 )
TOTAL ASSETS LESS CURRENT LIABILITIES (10,602 )
NET LIABILITIES (10,602 )
CAPITAL AND RESERVES (10,602 )

Notes

1. General Information
Immune Booster Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15494603 . The registered office is 165 - 167 The Broadway, Highland House, London, SW19 1NE.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr V Frais
Director
30/04/2025